• Mashup Score: 4
    Home - 11 month(s) ago

    Tweet Tweets with this article
    • It would be great to have additional validated predictive markers to help us better select patients most profiting from LuPSMA. Let’s discuss at @APCCC_Lugano! By the way check out our new website https://t.co/k6XPxvmVhz ! https://t.co/pqsIxvGNGc

  • Mashup Score: 0

    About ScienceDirectRemote accessShopping cartAdvertiseContact and supportTerms and conditionsPrivacy policyWe use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies.Copyright © 2023 Elsevier B.V. or its licensors or contributors. ScienceDirect® is a registered trademark of Elsevier B.V.ScienceDirect® is a registered trademark…

    Tweet Tweets with this article
    • Some arguments at https://t.co/rZ06HqKt8H https://t.co/mR0abEhu0K

  • Mashup Score: 0

    About ScienceDirectRemote accessShopping cartAdvertiseContact and supportTerms and conditionsPrivacy policyWe use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies.Copyright © 2023 Elsevier B.V. or its licensors or contributors. ScienceDirect® is a registered trademark of Elsevier B.V.ScienceDirect® is a registered trademark…

    Tweet Tweets with this article
    • Voting results from APCCC 2022 @APCCC_Lugano https://t.co/yponJ1c3du

  • Mashup Score: 2

    About ScienceDirectRemote accessShopping cartAdvertiseContact and supportTerms and conditionsPrivacy policyWe use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies.Copyright © 2022 Elsevier B.V. or its licensors or contributors. ScienceDirect ® is a registered trademark of Elsevier B.V.ScienceDirect ® is a registered…

    Tweet Tweets with this article
    • Interestingly in this retrospective analysis there was no effect of metformin, we need to wait for the prospective studies @Prof_Nick_James https://t.co/k5tw1Kj8Xx

  • Mashup Score: 0
    Home | STAMPEDE - 2 year(s) ago

    Prostate cancer accounts for around one fifth of all male cancers. In the UK there are ~47,000 new cases each year and ~11,000 deaths. STAMPEDE aims to provide evidence as to what is the best way of treating men with newly diagnosed advanced prostate cancer. Since opening in 2005 over 10 000 participants have…

    Tweet Tweets with this article
    • At https://t.co/fUBkZiRnhH you can find also summaries for patients. We hope they are useful. Feedback always welcome! https://t.co/oDB3e8etj1

  • Mashup Score: 2

    The APC Executive Committee is highly conscientious of the impact that the current COVID-19 pandemic has on travel and event restrictions. We strongly believe in mitigating the spread of the virus while still maintaining the ability to facilitate the exchange between experts, and positively impact the lives of patients with advanced prostate cancer.Therefore the APCCC 2022 is planned as a hybrid…

    Tweet Tweets with this article
    • And as a first: On the day before APCCC (April 27th) a translational meeting, Registration also at https://t.co/fPN1UjMfsX. @MarkARubin1 @JTheurillat @mishabeltran @AttardLab @felixfengmd https://t.co/tYHCDsTFOd https://t.co/i0oP0vLzxd